Citadel Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $996M | Sell |
|
|||||
2025
Q1 | $970M | Buy |
|
|||||
2024
Q4 | $697M | Buy |
|
|||||
2024
Q3 | $131M | Buy |
|
|||||
2024
Q2 | $57.7M | Sell |
|
|||||
2024
Q1 | $253M | Buy |
|
|||||
2023
Q4 | $23.3M | Sell |
|
|||||
2023
Q3 | $40.9M | Buy |
|
|||||
2023
Q2 | $528K | Sell |
|
|||||
2023
Q1 | $82.1M | Buy |
|
|||||
2022
Q4 | $35.5M | Buy |
|
|||||
2022
Q3 | $29.9M | Buy |
|
|||||
2022
Q2 | $840K | Sell |
|
|||||
2022
Q1 | $2.15M | Sell |
|
|||||
2021
Q4 | $4.15M | Sell |
|
|||||
2021
Q3 | $20.4M | Buy |
|
|||||
2021
Q2 | $7.27M | Sell |
|
|||||
2021
Q1 | $62M | Buy |
|
|||||
2020
Q4 | $42.7M | Buy |
|
|||||
2020
Q3 | $5.22M | Sell |
|
|||||
2020
Q2 | $13.4M | Sell |
|
|||||
2020
Q1 | $88.9M | Buy |
|
|||||
2019
Q4 | $20.6M | Sell |
|
|||||
2019
Q3 | $229M | Buy |
|
|||||
2019
Q2 | $107M | Sell |
|
|||||
2019
Q1 | $156M | Buy |
|
|||||
2018
Q4 | $233K | Buy |
|
|||||
2018
Q3 | – | Sell |
|
|||||
2018
Q2 | $10.5M | Sell |
|
|||||
2018
Q1 | $10.7M | Sell |
|
|||||
2017
Q4 | $121M | Sell |
|
|||||
2017
Q3 | $146M | Sell |
|
|||||
2017
Q2 | $244M | Buy |
|
|||||
2017
Q1 | $112M | Buy |
|
|||||
2016
Q4 | $79.8M | Sell |
|
|||||
2016
Q3 | $213M | Buy |
|
|||||
2016
Q2 | $32.9M | Sell |
|
|||||
2016
Q1 | $112M | Buy |
|
|||||
2015
Q4 | $35.2M | Sell |
|
|||||
2015
Q3 | $316M | Buy |
|
|||||
2015
Q2 | $178M | Buy |
|
|||||
2015
Q1 | $55.9M | Buy |
|
|||||
2014
Q4 | $30.1M | Sell |
|
|||||
2014
Q3 | $40.2M | Buy |
|
|||||
2014
Q2 | $18.3M | Buy |
|
|||||
2014
Q1 | $1.33M | Sell |
|
|||||
2013
Q4 | $1.41M | Sell |
|
|||||
2013
Q3 | $9.49M | Buy |
|
|||||
2013
Q2 | $549K | Buy |
|